Wall Street Analysts Are Bullish on Top Healthcare Picks
There's a lot to be optimistic about in the Healthcare sector as 2
analysts just weighed in on Resmed (RMD – Research Report) and
UnitedHealth (UNH – Research Report) with bullish sentiments.
Resmed (RMD) RBC Capital analyst Craig Wong-Pan maintained a Buy
rating on Resmed on July 18 and set a price target of $246.00. The
company's shares closed last Wednesday at $226.90.
から 9 2022 まで 10 2022
から 10 2021 まで 10 2022